ClinicalTrials.gg
Sign In

Dermatitis, Allergic Contact clinical trials

The registry lists 52 studies for Dermatitis, Allergic Contact across more than 10 countries. 11 are recruiting or about to start. 44 of them are mainly about Dermatitis, Allergic Contact (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-09.

Get an email when these change. Save the Dermatitis, Allergic Contact studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
31
Status unknown
6
Not yet recruiting
6
Recruiting
4
Active, not recruiting
2
Enrolling by invitation
1

Phase

Phase 2
7
Phase 4
6
Phase 1
4
Phase 3
2
Early Phase 1
1

Where

United States
23
Denmark
9
Canada
4
France
3
Sweden
2
Italy
2

Who runs them

National Allergy Research Center, Denmark (4) · Herlev and Gentofte Hospital (3) · Mekos Laboratories AS (3) · Hospices Civils de Lyon (3) · Allerderm (3) · NeXtGen Biologics, Inc. (2) · NYU Langone Health (2) · The University of Texas Health Science Center, Houston (2)

What is being tested here

Drugs under test in Dermatitis, Allergic Contact studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dupilumab012
Interleukin 1 Receptor Antagonist Protein011
Baricitinib001
Hyaluronidase (human recombinant)001
Apremilast001
Bacitracin001
Calcipotriene001
Betamethasone001

Coming up

1phase 3 study under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 4 Dermatitis, Allergic Contact studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
100 (0%)0 (0%)
184 (100%)4 (100%)
304 (100%)4 (100%)
404 (100%)4 (100%)
504 (100%)4 (100%)
654 (100%)4 (100%)
754 (100%)4 (100%)
854 (100%)4 (100%)

Across all 52 studies, recruiting or not: 35% stop at 75 or younger and 31% at 65; 13% take children; 4% are for women only and 2% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dermatitis, Allergic Contact studies take

Of 14 interventional studies with no phase under Dermatitis, Allergic Contact, half reached primary completion within 7 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase7 mo4–21 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 52. Browse all 52 → or search them.